14 Best Booming Stocks to Buy Right Now

Page 3 of 13

11. Structure Therapeutics Inc. (NASDAQ:GPCR)

Upside Potential: 49.94%

3M Returns: 131.66%

Number of Hedge Fund Holders: 42

Structure Therapeutics Inc. (NASDAQ:GPCR) is among the 14 best booming stocks to buy right now. The company’s shares have gained over 130% in the past three months, with a major surge since early December after reporting positive data related to its oral obesity pill.

A study testing aleniglipron on obese or overweight patients, with one or more co-morbidities tied to weight, demonstrated a weight loss of 11.3% after being treated for 36 weeks at a dosage of 120 mg. This was a significant development, given that most of the market is concentrated in injectables.

Structure Therapeutics Inc. (NASDAQ:GPCR) also shared that there is another clinical research ongoing, testing participants with a 240 mg dose, which produced even better results, with a weight loss of 15.3% at 36 weeks.

In other news, on December 17, the company announced that it was beginning the first human-based trial of ACCG-2671, an oral small-molecule amylin receptor to treat obesity.

Wall Street analysts have a bullish outlook for the stock, with a consensus Strong Buy rating and a one-year average share price target of $104, representing an upside of 49.94%, as of the close on January 12.

Recent analyst updates include one from LifeSci Capital on January 6, where it reiterated a Buy rating on the stock with a price target of $107. This followed BMO Capital maintaining its Outperform rating on January 2, with a price target of $130.

Structure Therapeutics Inc. (NASDAQ:GPCR) is a biotechnology company focused on the development of treatments for chronic metabolic conditions.

Page 3 of 13